180 related articles for article (PubMed ID: 2861170)
21. Effects of naloxone and D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 and the protein kinase inhibitors H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice.
Bilsky EJ; Bernstein RN; Wang Z; Sadée W; Porreca F
J Pharmacol Exp Ther; 1996 Apr; 277(1):484-90. PubMed ID: 8613958
[TBL] [Abstract][Full Text] [Related]
22. Analgesic effect of agmatine and its enhancement on morphine analgesia in mice and rats.
Li J; Li X; Pei G; Qin BY
Zhongguo Yao Li Xue Bao; 1999 Jan; 20(1):81-5. PubMed ID: 10437131
[TBL] [Abstract][Full Text] [Related]
23. In vivo studies on spinal opiate receptor systems mediating antinociception. II. Pharmacological profiles suggesting a differential association of mu, delta and kappa receptors with visceral chemical and cutaneous thermal stimuli in the rat.
Schmauss C; Yaksh TL
J Pharmacol Exp Ther; 1984 Jan; 228(1):1-12. PubMed ID: 6319664
[TBL] [Abstract][Full Text] [Related]
24. [Comparison of the antagonistic effects of 6 beta-naltrexol and naltrexone against morphine analgesia].
Yan LD; Gong ZH; Yao XJ; Qin BY
Yao Xue Xue Bao; 2003 Aug; 38(8):578-81. PubMed ID: 14628446
[TBL] [Abstract][Full Text] [Related]
25. Analgesic activity and pharmacological characterization of N-[1-phenylpyrazol-3-yl]-N-[1-(2-phenethyl)-4-piperidyl] propenamide, a new opioid agonist acting peripherally.
Goicoechea C; Sánchez E; Cano C; Jagerovic N; Martín MI
Eur J Pharmacol; 2008 Oct; 595(1-3):22-9. PubMed ID: 18706410
[TBL] [Abstract][Full Text] [Related]
26. Irreversible opioid antagonist effects of clocinnamox on opioid analgesia and mu receptor binding in mice.
Burke TF; Woods JH; Lewis JW; Medzihradsky F
J Pharmacol Exp Ther; 1994 Nov; 271(2):715-21. PubMed ID: 7965787
[TBL] [Abstract][Full Text] [Related]
27. Involvement of I2-imidazoline binding sites in positive and negative morphine analgesia modulatory effects.
Gentili F; Cardinaletti C; Carrieri A; Ghelfi F; Mattioli L; Perfumi M; Vesprini C; Pigini M
Eur J Pharmacol; 2006 Dec; 553(1-3):73-81. PubMed ID: 17081513
[TBL] [Abstract][Full Text] [Related]
28. Measurement of the analgesic efficacy and potency of pentazocine by the D'Amour and Smith method.
Gray WD; Osterberg AC; Scuto TJ
J Pharmacol Exp Ther; 1970 Mar; 172(1):154-62. PubMed ID: 5416940
[No Abstract] [Full Text] [Related]
29. Maximum tolerated temperature in the rat tail: a broadly sensitive test of analgesic activity.
Farré AJ; Colombo M; Gutiérrez B
Methods Find Exp Clin Pharmacol; 1989 May; 11(5):303-7. PubMed ID: 2755276
[TBL] [Abstract][Full Text] [Related]
30. Agonist and antagonist interactions of opioids on acetic acid-induced abdominal stretching in mice.
Taber RI; Greenhouse DD; Rendell JK; Irwin S
J Pharmacol Exp Ther; 1969 Sep; 169(1):29-38. PubMed ID: 5804610
[No Abstract] [Full Text] [Related]
31. Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans.
Ananthan S; Kezar HS; Carter RL; Saini SK; Rice KC; Wells JL; Davis P; Xu H; Dersch CM; Bilsky EJ; Porreca F; Rothman RB
J Med Chem; 1999 Sep; 42(18):3527-38. PubMed ID: 10479286
[TBL] [Abstract][Full Text] [Related]
32. [The pharmacologic effect of flupirtine, a structurally new analgesic].
Jakovlev V; Sofia RD; Achterrath-Tuckermann U; von Schlichtegroll A; Thiemer K
Arzneimittelforschung; 1985; 35(1):30-43. PubMed ID: 2985093
[TBL] [Abstract][Full Text] [Related]
33. Enhancement mu opioid antinociception by oral delta9-tetrahydrocannabinol: dose-response analysis and receptor identification.
Cichewicz DL; Martin ZL; Smith FL; Welch SP
J Pharmacol Exp Ther; 1999 May; 289(2):859-67. PubMed ID: 10215664
[TBL] [Abstract][Full Text] [Related]
34. [Analgesic and narcotic antagonist effects of buprenorphine (author's transl)].
Hiyama T; Shintani S; Tsutsui M; Yasuda Y
Nihon Yakurigaku Zasshi; 1982 Mar; 79(3):147-62. PubMed ID: 7084817
[TBL] [Abstract][Full Text] [Related]
35. Morphine sex-dependently induced place conditioning in adult Wistar rats.
Karami M; Zarrindast MR
Eur J Pharmacol; 2008 Mar; 582(1-3):78-87. PubMed ID: 18191832
[TBL] [Abstract][Full Text] [Related]
36. Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice.
Kögel B; Christoph T; Strassburger W; Friderichs E
Eur J Pain; 2005 Oct; 9(5):599-611. PubMed ID: 16139189
[TBL] [Abstract][Full Text] [Related]
37. Analgesic profile of rimazolium as compared to different classes of pain killers.
Furst S; Gyires K; Knoll J
Arzneimittelforschung; 1988 Apr; 38(4):552-7. PubMed ID: 3261171
[TBL] [Abstract][Full Text] [Related]
38. Opiate and acetylcholine-independent analgesic actions of crotoxin isolated from crotalus durissus terrificus venom.
Zhang HL; Han R; Chen ZX; Chen BW; Gu ZL; Reid PF; Raymond LN; Qin ZH
Toxicon; 2006 Aug; 48(2):175-82. PubMed ID: 16857228
[TBL] [Abstract][Full Text] [Related]
39. The competitive alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist LY293558 attenuates and reverses analgesic tolerance to morphine but not to delta or kappa opioids.
Kest B; McLemore G; Kao B; Inturrisi CE
J Pharmacol Exp Ther; 1997 Dec; 283(3):1249-55. PubMed ID: 9400000
[TBL] [Abstract][Full Text] [Related]
40. Oxilorphan (l-N-cyclopropylmethyl-3,14-dihydroxymorphinan): a new synthetic narcotic antagonist.
Pircio AW; Gylys JA
J Pharmacol Exp Ther; 1975 Apr; 193(1):23-34. PubMed ID: 237112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
